Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 2010 April; 54(4): 1580–1589.
Published online 2010 January 19. doi:  10.1128/AAC.01158-09
PMCID: PMC2849382

Neutrophil Gelatinase-Associated Lipocalin Expresses Antimicrobial Activity by Interfering with l-Norepinephrine-Mediated Bacterial Iron Acquisition[down-pointing small open triangle]


l-norepinephrine (NE) is a neuroendocrine catecholamine that supports bacterial growth by mobilizing iron from a primary source such as holotransferrin to increase its bioavailability for cellular uptake. Iron complexes of NE resemble those of bacterial siderophores that are scavenged by human neutrophil gelatinase-associated lipocalin (NGAL) as part of the innate immune defense. Here, we show that NGAL binds iron-complexed NE, indicating physiological relevance for both bacterial and human iron metabolism. The fluorescence titration of purified recombinant NGAL with the FeIII·(NE)3 iron complex revealed high affinity for this ligand, with a KD of 50.6 nM. In contrast, the binding protein FeuA of Bacillus subtilis, which is involved in the bacterial uptake of triscatecholate iron complexes, has a KD for FeIII·(NE)3 of 1.6 μM, indicating that NGAL is an efficient competitor. Furthermore, NGAL was shown to inhibit the NE-mediated growth of both E. coli and B. subtilis strains that either are capable or incapable of producing their native siderophores enterobactin and bacillibactin, respectively. These experiments suggest that iron-complexed NE directly serves as an iron source for bacterial uptake systems, and that NGAL can function as an antagonist of this iron acquisition process. Interestingly, a functional FeuABC uptake system was shown to be necessary for NE-mediated growth stimulation as well as its NGAL-dependent inhibition. This study demonstrates for the first time that human NGAL not only neutralizes pathogen-derived virulence factors but also can effectively scavenge an iron-chelate complex abundant in the host.

For the purpose of high-affinity iron acquisition, microbes use a broad array of iron chelators, known as siderophores, that are secreted by their own species, by other microbes, or by the host organism (11, 40, 50). Mammalian pathogens in particular have to cope with strong iron-deprived conditions. There, iron is tightly bound to host proteins, such as serum transferrin, ferritin, or lactoferrin, which leads to an availability of the free metal ion in plasma at concentrations as low as 10−24 M (47). Thus, for successful iron acquisition, mammalian pathogens require siderophores with extraordinary affinities.

Among the three general siderophore classes (40), those of the catecholate type have the highest known Fe3+ affinities. Two outstanding examples are the triscatecholate siderophores enterobactin (Ent) and bacillibactin (BB) of enteric bacteria such as Escherichia coli and Bacillus spp., respectively (Fig. (Fig.1).1). These siderophores have extremely high complex formation constants, with log Kf (complex formation constant) = 49 for Ent (35) and log Kf = 47.6 for BB (13). The acute-phase protein NGAL (also known as lipocalin 2 or siderocalin) sequesters both iron-charged Ent and BB with dissociation constants in the range of 0.4 to 0.5 nM (3, 19, 25), which in the case of Ent was shown to be pivotal in the innate immune response to bacterial infection (20).

FIG. 1.
Chemical structures of neuroendocrine catecholamines shown in the order of their biosynthetic conversion (top), as well as siderophores with known affinity to NGAL (bottom). Enterobactin is produced by enteric bacteria, bacillibactin is produced by Bacillus ...

During coevolution, pathogens evaded NGAL-mediated defense either by the C5 glucosylation of Ent, leading to salmochelins (17, 26), or by developing novel siderophores such as petrobactin (3). However, crystallographic studies revealed that NGAL also is able to bind carboxymycobactins produced by Mycobacterium spp. as well as parabactin from Paracoccus denitrificans (28), a structural analog of vibriobactin from Vibrio cholerae (Fig. (Fig.1).1). Thus, the NGAL pocket shows a certain plasticity for accommodating a heterogeneous set of catecholic and phenolic iron chelators, which raises the question of whether further interactions with ligands of physiological relevance exist.

Interestingly, small catecholic compounds have Fe3+ complex formation constants that enable them to abstract iron from transferrin, which has a logarithmic association constant of around 22 (36), and from other iron-binding proteins. The complex formation constant of Fe3+·(catechol2−)3, for example, is impressively high, with log Kf = 45.9 (31). Thus, even though the bacterial triscatecholate siderophores clearly show greatly superior iron affinities compared to those of iron-binding host proteins, pathogens may benefit not only from iron that is acquired by their own siderophores but also from related catecholic compounds with chelating activity derived from the host.

Indeed, previous studies have shown that commensal or pathogenic bacteria such as Escherichia coli (9, 22, 23), Salmonella enterica (6, 60), Vibrio parahaemolyticus (42), Klebsiella pneumoniae (45), Pseudomonas aeruginosa (45), Enterobacter sp. (45), Shigella sonnei (45), Staphylococcus aureus (45), Listeria spp. (10), and Bordetella bronchiseptica (4) utilize neuroendocrine catecholamines such as l-norepinephrine (NE) and l-epinephrine (EPI), as well as their progenitors l-3,4-dihydroxyphenylalanine (l-DOPA) and dopamine (Fig. (Fig.1)1) to acquire iron that is bound to serum transferrin or, in some cases, lactoferrin. Studies with E. coli and S. enterica suggested that the Ent system is involved in catecholamine-mediated iron acquisition (6, 9, 22).

However, components of the Ent utilization pathway were shown to be downregulated in the presence of NE, possibly due to Fur activation as a result of NE-mediated iron delivery (6, 16). In this context, mutational analyses in S. enterica and E. coli revealed that the utilization of NE as an iron source depends on the presence of the Cir outer membrane receptor and on the TonB energy system for substrate translocation (22, 60). NE was further shown to complement intragastical Ent- and salmochelin-mediated iron acquisition of S. enterica in a mouse model system, leading to the systemic spread of strains with a functional Cir uptake system (60).

In the present study, we demonstrate that iron-complexed l-norepinephrine [FeIII·(NE)3] is tightly bound by NGAL. E. coli and Bacillus subtilis strains that are deficient in the production of endogenous siderophores are shown to accept NE as an iron source for growth support, with the FeuABC uptake system of B. subtilis participating in NE utilization. Growth no longer is supported by NE in cultures supplemented with NGAL, thus suggesting its role as a physiological FeIII·(NE)3 scavenger.


Recombinant protein production and purification.

All proteins were produced in E. coli strain BL21 (53). Human NGAL was expressed with N-terminal OmpA signal peptide and C-terminal Strep-tag II from the vector phNGAL14 as described previously (8). Alternatively, Strep-tag II was exchanged for a C-terminal His6 tag, yielding the vector pNGAL99. Human tear lipocalin (Tlc) was expressed similarly with N-terminal OmpA signal peptide and the C-terminal Strep-tag II from the vector pTlc3 (8). B. subtilis FeuA was expressed in the bacterial cytoplasm as C-terminal His6 tag fusion protein from vector pOK01 (39).

Recombinant NGAL and Tlc were purified from the periplasmic cell extract as previously described (8). For the production of FeuA, cells were grown in shake flask cultures at 30°C under agitation in LB medium containing 50 μg/ml kanamycin (Kan). At an optical density at 550 nm (OD550) of 0.7, 0.1 mM isopropyl-β-d-thiogalactopyranoside (IPTG) was added to induce gene expression, which was continued for 4 h. Cells were harvested and resuspended in 100 mM NaCl, 50 mM NaPi, pH 7.5. Cells then were disrupted by means of a French press, and debris were removed by centrifugation. The clear supernatant was applied onto an IDA-Sepharose column (GE Healthcare, Munich, Germany) charged with ZnSO4, and the His6-tagged protein was eluted with a linear imidazole concentration gradient from 0 to 250 mM in 100 mM NaCl, 50 mM NaPi, pH 7.5. Elution fractions were pooled, concentrated by ultrafiltration, and applied to gel filtration in the presence of 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, on a HiLoad 16/60 Superdex 75 column using an Äkta purifier system (GE Healthcare). To remove a contamination of slightly smaller size, the fractions containing the recombinant FeuA (pI = 7.2) were dialyzed against 20 mM Tris-HCl, pH 8.5, and loaded onto a 1-ml Resource Q column (GE Healthcare) on an Äkta purifier system. Elution was performed with a linear NaCl concentration gradient from 0 to 500 mM in 20 mM Tris-HCl, pH 8.5, over 40 column volumes at a flow rate of 1 ml/min. Elution fractions were analyzed by SDS-PAGE, and pure fractions were pooled and dialyzed against 100 mM NaCl, 10 mM Tris-HCl, pH 8.0. The protein concentration was determined using a molar extinction coefficient as previously reported (39).

Fluorescence titration.

Fluorescence titration studies were performed essentially as previously described (8). The protein solution in 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, was adjusted to the desired concentration, and 2 ml of this solution was applied to a 1- by 1-cm2 quartz cuvette. The cuvette was placed into a Fluoro-Max 3 spectrofluorimeter (Horiba Jobin Yvon, Longjumeau, France) and thermostatted at 20°C. Ligand stock solutions concentrated 2,000-fold [200-fold in the case of FeuA titration with NE or FeIII·(NE)3] with respect to the molar protein concentration were freshly prepared in H2O. Siderophore ligands enterobactin (Ent) and bacillibactin (BB) were obtained in synthetic form or were isolated from bacterial cultures, respectively, as previously described (18, 39). Catecholamines l-norepinephrine (NE), l-epinephrine (EPI), l-DOPA, and dopamine were purchased (Alfa Aesar, Karlsruhe, Germany). For charging with iron, ligand solutions were mixed with a fresh FeCl3 (Sigma-Aldrich, Munich, Germany) solution in H2O at the appropriate molar stoichiometry, followed by incubation for 5 min at 20°C. Defined amounts of the iron-ligand solution then were added stepwise to the protein solution. After each titration step, the solution was mixed for 3 min by magnet stirring in the cuvette and then rested for another 2 min before fluorescence was measured. The protein Tyr/Trp fluorescence was excited at 280 nm (slit width, 5 nm) and detected at 340 nm (slit width, 10 nm). Each measurement was averaged for 10 s. In the case of iron-charged enterobactin and bacillibactin, ligand absorption was corrected after analogous titration with a 5 μM N-acetyl-tryptophanamide solution as described previously (59). For the analysis of the fluorescence titration series, data were set to a 100% starting fluorescence intensity and fitted according to the law of mass action for bimolecular complex formation (57) by nonlinear regression analysis (KaleidaGraph software) using the equation

equation M1

where [P]t and [L]t are total protein and ligand concentrations at each titration step, respectively; fP, fL, and fPL are the relative molar fluorescence coefficients of the free protein, the free ligand, and the protein-ligand complex, respectively; and KD is the dissociation constant. KD and fPL were set as free parameters, while fP was adjusted to the starting fluorescence without ligand (e.g., 100%/μM). In the case of iron-catecholamine complexes, fL was set as an additional free parameter to account for intrinsic ligand fluorescence. All titrations also were carried out with either bovine serum albumin (BSA; Sigma-Aldrich) as a control protein or FeCl3 as a control ligand.

Cell growth assays.

B. subtilis strains ATCC 21332 (37), ΔdhbC (BMM100), and ΔdhbC ΔfeuABC (BMM111) (39) were grown in Belitsky minimal medium (54) with 0.5% (wt/vol) glucose, 4.5 mM Na-glutamate, with the omission of citrate and iron salts. E. coli strains MC4100 (63) and ΔentC (H5687) (63) were grown in SAPI minimal medium (9) with 0.1% (wt/vol) glucose and 0.001% (wt/vol) thiamine, again with the omission of iron salts. Colonies from each strain freshly grown on LB plates (49) were used for the inoculation of minimal medium, followed by incubation in polypropylene culture tubes at 37°C and 200 rpm for about 12 h. The cell densities of the iron-limited overnight cultures were measured, and cultures were diluted with fresh minimal medium to 103 CFU/ml. Diluted cultures then were transferred into 96-well round-bottom polystyrene plates (Nunc, Wiesbaden, Germany) to 100 μl/well. Additional components, i.e., NGAL, Tlc, apotransferrin (apoTf; ICN Biomedicals, Eschwege, Germany), holotransferrin (holoTf; Calbiochem, Darmstadt, Germany), NE, EPI, and FeCl3, were supplemented in three independent wells for each combination or concentration tested. Empty wells were filled with 100 μl sterile medium for the control of contamination and to ensure the homogeneity of a humid atmosphere. Plates were incubated with a lid at 37°C and 500 rpm for 20 h on a microtiter plate shaker (Eppendorf, Hamburg, Germany). For viable cell counting, 20-μl samples were taken from each well, including three controls. Eight successive 10-fold dilutions were made from each sample using sterile medium, followed by plating onto LB agar. Colony counts for each triplicate were averaged and plotted with the corresponding standard deviations. For the determination of half-maximal inhibitory concentrations (IC50), colony averages from inhibition cultures were related to those obtained without the addition of inhibitor, and curves were plotted and analyzed according to the model of logarithmic dose-response (Origin software) using the sigmoidal equation

equation M2

where cfui and cfuc are the averaged cell counts of inhibition and control cultures, respectively, Amax and Amin are the top and the bottom parameters of the curve, respectively, [I]tot is the total inhibitor concentration, and p is the logarithmic slope.

Protein crystallization and ligand soaking.

A 24.8-mg/ml solution of purified recombinant NGAL carrying the C-terminal Strep-tag II in 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, was subjected to hanging drop vapor diffusion crystallization in combination with microseeding at 20°C (38). Crystals were obtained in the presence of 0.1 M Bis/Tris-HCl, pH 5.5, 34.5% (wt/vol) polyethylene glycol (PEG) 3350. Ligand soaking was performed for about 24 h under a nitrogen atmosphere by transferring crystals into fresh precipitant solution containing 0.44 mM FeIII·(NE)3 and, to prevent ligand precipitation, having a higher pH (0.1 M HEPES-NaOH, pH 7.5, 34.5% [wt/vol] PEG 3350).


Binding of iron-complexed NE to NGAL and FeuA.

Since NGAL is known as a high-affinity scavenger of bacterial catecholate and phenolate siderophores, we investigated whether this protein also is capable of sequestering iron-chelating host molecules with chemically related structures. In this regard, neuroendocrine catecholamines, which often are utilized by microbes as iron sources, appeared to be of particular interest. Thus, corresponding binding studies were performed by the fluorescence titration of recombinant NGAL (Fig. (Fig.2).2). Titration with iron-complexed NE led to a pronounced fluorescence quenching effect (Fig. (Fig.3).3). After correction for the intrinsic fluorescence of catecholamine complexes (44), a KD value of 50.6 ± 9.3 nM (Table (Table1)1) was determined for the interaction between the preformed FeIII·(NE)3 complex (31) and NGAL.

FIG. 2.
SDS-PAGE of purified proteins used in this study. The recombinant proteins NGAL and Tlc, both fused at the C terminus with the Strep-tag II, as well as FeuA fused at the C terminus with the His6 tag, all were produced in E. coli. M, protein size marker. ...
FIG. 3.
Fluorescence titration of recombinant NGAL and FeuA with bacterial siderophores or neuroendocrine catecholamines. (A) One μM NGAL was titrated with the preformed Fe3+ complex of l-norepinephrine [FeIII·(NE)3]. (B) One μM ...
Dissociation constants of protein-ligand complexes determined by fluorescence titration

In contrast to NE, titration with iron-complexed EPI (Fig. (Fig.3B)3B) and also with l-DOPA (not shown) did not result in detectable fluorescence quenching, indicating that the iron complexes of these catecholamines do not bind to NGAL with significant affinity. As expected, titration with the known ligands FeIII·Ent and FeIII·BB led to strong fluorescence quenching (Fig. (Fig.3C,3C, D), and the resulting KD values of 0.40 ± 0.15 and 0.52 ± 0.16 nM, respectively, are in agreement with previous reports (3, 25). Titration with dopamine was not possible, since its complexation with Fe3+ led to a precipitate, possibly due to metal-catalyzed melanine formation (34).

Although bacteria have been described to utilize iron mobilized by NE and other catecholamines, it still is unclear to what extent iron-complexed catecholamines directly serve as substrates for bacterial uptake systems. Thus, the substrate binding protein FeuA of B. subtilis, an extracytoplasmic lipoprotein that scavenges iron-charged triscatecholate siderophores prior to their uptake via the FeuBC/YusV membrane permease/ATP-binding cassette complex (39, 46), was tested for its ability to recognize iron-complexed NE. Titration of the recombinant FeuA (Fig. (Fig.2)2) with FeIII·(NE)3 resulted in fluorescence quenching (Fig. (Fig.3E)3E) with a KD of 1.6 ± 0.2 μM, whereas the titration of FeuA with its native ligand FeIII·BB yielded a lower KD of 26.5 ± 1.4 nM (Fig. (Fig.3F),3F), which is in agreement with earlier measurements (39). Notably, the 30-fold-lower affinity of FeuA for FeIII·(NE)3 compared to that of NGAL indicates that the latter can act as a potent competitor in binding of this iron complex. The titration of NGAL and FeuA with catecholamine ligands in the absence of Fe3+ did not lead to detectable fluorescence quenching, while titration with FeCl3 in the higher-micromolar range resulted in unspecific quenching both of the test proteins and of BSA, which served as a negative control.

In earlier experimental studies, the soaking of NGAL protein crystals with iron-complexed siderophores was accompanied by a color change to red-brown, qualitatively indicating accommodation in the ligand pocket of this lipocalin (2, 3, 19). Consequently, we soaked freshly grown crystals of the recombinant NGAL with FeIII·(NE)3 at pH 7.5 and, indeed, the crystals turned from colorless to deep red, while the crystal morphology remained unaffected (Fig. (Fig.2).2). This observation further supports that iron-complexed NE tightly binds to NGAL in a most likely native conformation, which also should allow the structural elucidation of the complex via X-ray crystallography in the future.

Growth of E. coli and B. subtilis strains in the presence of NE and NGAL.

E. coli MC4100 and B. subtilis ATCC 21332 were used as Gram-negative and Gram-positive model strains, respectively, which synthesize the natural triscatecholate siderophores Ent and BB. Since these siderophores are considered the major targets of sequestration by NGAL (3, 25), cross-binding effects were avoided by using mutant strains deficient in siderophore biosynthesis. The E. coli ΔentC and B. subtilis ΔdhbC mutants lack isochorismate synthase activity (39, 63), thus abolishing the biosynthesis of both the triscatecholate siderophores and their common precursor 2,3-dihydroxybenzoate (DHB), an alternative siderophore that can form an FeIII·(DHB)3 complex recognized by NGAL (25).

In a first growth experiment, iron-limited cultures with 103 CFU/ml starting inocula were supplemented with 50 μM NE, holotransferrin (holoTf), apotransferrin (apoTf), NGAL, and FeCl3 in different combinations. An NE concentration of 50 μM previously was identified to be optimal for the growth of E. coli under similar in vitro conditions (9) and furthermore corresponds to the physiological situation, for example, during traumatic injury in vivo (24, 55, 56). The concentration of 50 μM for Tf was chosen according to its abundance in vivo (48). After 20 h of culture growth, viable plate counts were determined and CFU were plotted (Fig. (Fig.44).

FIG. 4.
Cell growth assays with B. subtilis and E. coli wild-type (WT) and siderophore biosynthesis mutant strains. (A) Colony counts of B. subtilis WT (white bars) and E. coli WT (gray bars) cultures. (B to D) Colony counts of B. subtilis ΔdhbC (white ...

Neither wild-type (WT) nor mutant strains responded to the addition of NE alone. WT strains were growth stimulated by the addition of holoTf and, in contrast, showed reduced growth when NGAL was added to the cultures. The effects of holoTf and NGAL on WT growth indicated the involvement of their endogenous siderophores in iron acquisition, because the siderophore-deficient mutant strains did not respond to holoTf or NGAL alone. Interestingly, the mutants showed increased growth upon the combined addition of NE and holoTf, indicating that NE is sufficient to mobilize iron from holoTf for bacterial growth without the need of an endogenous siderophore or precursor. However, the triple combination of NE, holoTf, and NGAL led to a significant growth inhibition of WT as well as mutant strains, in particular when NGAL was added at a higher concentration (Fig. (Fig.4C),4C), thus demonstrating its antimicrobial activity.

Control cultures supplemented with apoTf alone or in combination with NE had no significant effect on growth (Fig. (Fig.4A,4A, B). The marginal growth stimulation of apoTf in combination with NE in the mutant cultures may have been due to residual iron contamination of the apo protein. Supplementation with FeCl3 led to growth enhancement in all cultures. However, no inhibition was observed in this case upon the addition of NGAL, confirming that the antimicrobial effect of NGAL is confined to conditions of iron limitation, under which siderophore-mediated iron acquisition is crucial.

The NGAL concentrations needed for half-maximal growth inhibition under those conditions, i.e., in the presence of 50 μM NE and 50 μM holoTf, were assessed in a separate experiment, resulting in IC50 values of 12.4 ± 1.4 and 73.3 ± 8.7 μM for B. subtilis WT and ΔdhbC strains and of 160.0 ± 14.2 and 211 ± 10.3 μM for E. coli WT and ΔentC strains, respectively (Fig. (Fig.5).5). These findings support a direct competitive effect between the bacterial uptake of iron-complexed NE and sequestration by NGAL.

FIG. 5.
Determination of half-maximal inhibitory concentrations (IC50) of NGAL with respect to bacterial growth in iron-limited cultures in the presence of 50 μM NE and 50 μM holoTf. (A) Dose-response curves of B. subtilis WT (filled circles) ...

Bacterial growth in the presence of EPI and Tlc.

Similarly to NGAL, Tlc is a member of the lipocalin family that exhibits the overall β-barrel fold with a central ligand pocket (7) and acts as a scavenger of microbial siderophores (21). In contrast to the plasma protein NGAL, however, Tlc mainly occurs in secretory fluids and its ligand spectrum is broader, with generally lower affinities. To test the effect of Tlc on NE-dependent growth, recombinant Tlc was produced and purified under similar conditions (Fig. (Fig.2)2) and was added in various concentrations to cultures supplemented with NE and holoTf (Fig. (Fig.4C).4C). In contrast to the addition of NGAL, which significantly reduced NE-dependent growth enhancement in ΔdhbC or ΔentC strains, the addition of Tlc had no detectable growth effect.

The influence of NGAL and Tlc also was tested in cultures supplemented with EPI and holoTf (Fig. (Fig.4D).4D). The growth enhancement observed in the presence of EPI and holoTf was comparable to NE-dependent growth stimulation. However, in this case, the addition of neither NGAL nor Tlc led to an inhibitory effect, indicating that EPI is not accessible for sequestration by both lipocalins. Tlc was further subjected to fluorescence titration with Fe3+ complexes of Ent, NE, and EPI. While titration with FeIII·Ent resulted in detectable fluorescence quenching, yielding a KD of 243.3 ± 50.7 nM, no quenching was observed with the iron-complexed catecholamines, indicating a lack of significant affinity.

The FeuABC uptake system is involved in NE-mediated iron acquisition.

The fluorescence titration studies had shown that the bacterial triscatecholate binding protein FeuA possesses affinity for iron-complexed NE (Fig. (Fig.3E).3E). Since the FeuABC transport system serves for the uptake of triscatecholic iron chelators in B. subtilis (39, 46), we tested whether an feuABC deletion influences NE-dependent growth enhancement and its inhibition in the presence of NGAL. The transporter deletion was introduced into the biosynthesis mutant ΔdhbC, yielding a ΔdhbC ΔfeuABC double mutant, and both strains were grown with the addition of NE, EPI, holoTf, NGAL, and Tlc in different combinations (Fig. (Fig.66).

FIG. 6.
Cell growth assays with mutant strains of B. subtilis, ΔdhbC and ΔdhbC ΔfeuABC, defective in siderophore biosynthesis and siderophore biosynthesis as well as triscatecholate uptake, respectively. (A) Colony counts of B. subtilis ...

While ΔdhbC showed NE- and EPI-dependent growth enhancement in the presence of holoTf, the catecholamine-dependent stimulation of growth clearly was impaired in the ΔdhbC ΔfeuABC background. In contrast, NGAL-mediated inhibition in a concentration-dependent manner was observed for NE-supplemented, but not for EPI-supplemented, ΔdhbC cultures, whereas this effect was abolished in the ΔdhbC ΔfeuABC double mutant. This strongly indicated that the FeuABC uptake system is involved in the utilization of iron-complexed catecholamines to acquire iron for cellular growth. In accordance with the fluorescence titration experiment, the missing NGAL-dependent cellular growth inhibition with holoTf/NE as the iron source in the absence of FeuABC indicates that the antimicrobial effect is due essentially to a direct competition for iron-complexed NE between NGAL and the FeuA(BC) uptake system of B. subtilis.


The bacterial utilization of neuroendocrine catecholamines as an iron source is an important aspect of microbe-host interactions. These compounds are abundant in all mammalian hosts such that pathogens could further benefit from increased levels during stress or disease states. For example, severe tissue damage in trauma or burn patients causes massive systemic release of NE that can spill over into the intestine, where commensal bacteria that otherwise are limited in iron availability frequently cause intraabdominal sepsis (23, 24).

In the present study, NE-mediated bacterial growth stimulation was observed in siderophore-deficient strains of E. coli and B. subtilis, demonstrating that NE can be utilized as a host-derived iron source that mobilizes this essential element from primary sources such as holoTf. In fact, NE previously was shown to effectively liberate iron from holoTf under dialysis conditions (22). In B. bronchiseptica, NE alone is sufficient to stimulate cellular growth in serum-supplemented medium and probably is taken up in a TonB-dependent manner, whereas the BfeA outer membrane receptor (OMR), which is NE inducible, is not required for growth stimulation (4, 5).

In E. coli, the utilization of NE as a direct iron source seems to be strain specific, since defective Ent biosynthesis did not result in NE-dependent growth stimulation in the mutant strains AN193 entA (9) and NCTC12900 (O157:H7) entA (22). However, radiolabeling experiments with [3H]NE and [55Fe]Tf resulted in the intracellular detection of both tritiated NE and the 55Fe isotope in strain E2348/69 (O127:H6), thus proving the potential for cellular uptake of iron-complexed NE (23). Notably, when an S. enterica iroN fepA double mutant was compared to an iroN fepA cir triple mutant, the latter was not growth supported by NE in vivo (60), indicating that the ability of direct FeIII·(NE)3 utilization varies with the individual uptake systems present in E. coli and its relatives. Nevertheless, these experiments showed that the Cir outer membrane receptor is crucial for NE utilization, which is in agreement with its ability to utilize the structurally related 2,3-dihydroxybenzoylserine as an iron source (26).

The virulence-related role of compounds such as NE or EPI, important hormones and neurotransmitters in the peripheral and central nervous system, illustrates the necessity for the host to control the overall availability of these compounds, in particular in the context of inflammation-associated physiological responses. In this respect, the present study demonstrates that the acute-phase protein NGAL is able to sequester iron-complexed NE and counteract NE-stimulated growth, which could provide the protection of the host against catecholamine-dependent pathogen spreading, at least in compartments where holoTf and NE are abundant (12, 36).

The affinity of NGAL for FeIII·(NE)3 was found to be significantly higher than that of bacterial FeuA, and indeed, competition with bacterial uptake, in particular via FeuABC, was demonstrated here by means of systematic growth analyses. On the other hand, Tlc, which previously was identified as another siderophore-binding protein in mammals, is unlikely to be involved in FeIII·(NE)3 sequestration. This underlines the distinct physiological properties of lipocalin family members even in the case of ligands with related structure and function (8).

The NGAL concentrations needed to achieve half-maximal bacterial growth inhibition were found to be in the micromolar range. In this context, it should be noted that affinities of OMRs such as FepA, which possesses a KD of <0.2 nM for FeIII·Ent, often are impressively high (43). Hence, the elevated NGAL concentrations needed for growth inhibition in E. coli cultures are consistent with an effective competition of the OMRs for their iron-triscatecholate substrates. Since high NGAL concentrations not only were necessary to compete with FepA-mediated FeIII·Ent uptake in the WT strain but also to effectively inhibit the growth of ΔentC in response to NE, an affinity similarly tight as that known between FepA and FeIII·Ent has to be anticipated for Cir and the iron-NE complex. In contrast, NGAL was found to compete more effectively with iron uptake in B. subtilis, which is in agreement with the general observation that substrate-binding proteins at the extracellular leaflet of the cytoplasmic membrane have lower affinities than OMRs recognizing the same substrate(s) (40). As an example, E. coli FepA has about 100-fold higher affinity for FeIII·Ent than the periplasmic binding protein FepB and its homolog FeuA (39, 52, 62).

Furthermore, enhanced NGAL-dependent growth inhibition in the WT cultures may result not only from the preferred binding of endogenously produced siderophores over exogenously supplied NE to the lipocalin but also from the preferred utilization of the native siderophores by bacterial triscatecholate binding proteins, such as B. subtilis FeuA or E. coli FepB, as shown by protein-ligand binding experiments in this and previous studies (39, 52).

Interestingly, although B. subtilis is a close relative of mammalian pathogens such as B. anthracis and B. cereus, it is a nonpathogenic bacterium that widely occurs in soil habitats. However, the present study shows that during iron-limited conditions, its growth is supported by catecholamines, such as NE and EPI. This becomes more reasonable considering that these compounds also are abundant in nonmammalian organisms, in particular soil-dwelling invertebrates (32, 58), and even in plants (33). In this context, catecholamines and their derivatives may represent important iron-mobilizing compounds for microbes living in the soil and other habitats outside mammalian hosts, a possibility that has not been considered so far.

Earlier binding experiments with FeIII·(2,3-DHB)3 and FeIII·(3,4-DHB)3 suggested that 3,4-substituted catecholic ligands cause steric conflicts within the ligand pocket of NGAL (3). However, as we were able to detect the binding of FeIII·(NE)3 to NGAL in solution and also observed the coloring of protein crystals upon soaking, it is possible that the precise arrangement of the substituents protruding from the aromatic ring plays a more important role than previously assumed (27). In fact, the modeling of FeIII·(NE)3 indicates that at least the lower part of this complex, which should reside at the bottom of the ligand pocket considering the crystal structure with bound FeIII·Ent (25), has a rather similar molecular shape and probably can undergo the same interactions with NGAL (Fig. (Fig.7).7). However, the geometry of the ligand complex should be more flexible in the case of FeIII·(NE)3, because the three individual metal-chelating groups are not covalently cross-linked. To elucidate the exact mode of binding to NGAL, crystallographic studies in the presence of FeIII·(NE)3 are under way.

FIG. 7.
Structural comparison of the FeIII·(NE)3 complex with FeIII·Ent. The coordinate set of FeIII·Ent was taken from a partially refined crystal structure of its complex with NGAL (PDB entry 1IL6; courtesy of R. Strong) and energy minimized ...

In addition to antimicrobiosis, the sequestration of iron-complexed NE by NGAL is the first example for the interaction of a host-derived ligand with this innate defense protein. The interaction of NGAL with siderophore-like host compound(s) previously was postulated, as this lipocalin extensively participates in iron trafficking throughout the body and is associated with physiological processes (41, 51). Indeed, NGAL seems to deliver scavenged iron-chelate complexes, such as FeIII·Ent, to the liver, the proximal tubules of the kidney, and the placenta via several endocytic pathways involving cell surface receptors such as megalin (29) and 24p3R (14). Furthermore, it was shown that the uptake of NGAL in complex with FeIII·Ent via 24p3R increases the intracellular iron pool, while the uptake of apoNGAL diminishes intracellular iron levels, which leads to cellular apoptosis (14, 15). NGAL-mediated iron trafficking can sufficiently complement Tf-mediated iron delivery, as observed in the metanephric mesenchyme, and has important physiological consequences, such as antiapoptotic effects for epithelial progenitors (61) and thyroid tumor cells (30).

Hence, it was proposed that mammals possess endogenous iron chelators that, similarly to enterobactin, may reside intracellularly (14) or are secreted and can extracellularly charge NGAL with iron. Indeed, siderophore-like activities were observed in the urine of humans, dogs, and mice, and a catechol-like constitution was anticipated for the responsible molecule(s) (51).

In light of our present findings, it is conceivable that catecholamines such as NE act as iron ligands for NGAL as part of physiological iron trafficking and delivery processes. Intracellular iron release from holo-NGAL after uptake into acidic endosomes should be possible with the acid-labile FeIII·(NE)3 complex in the same way as it was recently shown for the bacterial FeIII·Ent ligand (1). Thus, the present study suggests a role of the NGAL/FeIII·(NE)3 complex formation beyond pathogen defense, which deserves further investigation in the context of NGAL-mediated iron homeostasis.


We thank M. A. Marahiel (University of Marburg, Germany) for kindly providing B. subtilis strains, K. Hantke (University of Tübingen, Germany) for kindly providing strain E. coli H5687, and C. T. Walsh and M. A. Fischbach (Harvard Medical School, Boston, MA) for kindly providing synthetic enterobactin. The support by H. J. Kim during recombinant NGAL expression and characterization and by A. Eichinger and W. Meining (all at Technische Universität München) for help with protein crystallization is gratefully acknowledged.

This work was supported by a DFG research fellowship (MI 1265/1-1) to M.M.


[down-pointing small open triangle]Published ahead of print on 19 January 2010.


1. Abergel, R. J., M. C. Clifton, J. C. Pizarro, J. A. Warner, D. K. Shuh, R. K. Strong, and K. N. Raymond.2008. The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport. J. Am. Chem. Soc. 130:11524-11534. [PMC free article] [PubMed]
2. Abergel, R. J., E. G. Moore, R. K. Strong, and K. N. Raymond.2006. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition. J. Am. Chem. Soc. 128:10998-10999. [PMC free article] [PubMed]
3. Abergel, R. J., M. K. Wilson, J. E. Arceneaux, T. M. Hoette, R. K. Strong, B. R. Byers, and K. N. Raymond.2006. Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc. Natl. Acad. Sci. USA 103:18499-18503. [PubMed]
4. Anderson, M. T., and S. K. Armstrong.2006. The Bordetella Bfe system: growth and transcriptional response to siderophores, catechols, and neuroendocrine catecholamines. J. Bacteriol. 188:5731-5740. [PMC free article] [PubMed]
5. Anderson, M. T., and S. K. Armstrong.2008. Norepinephrine mediates acquisition of transferrin-iron in Bordetella bronchiseptica. J. Bacteriol. 190:3940-3947. [PMC free article] [PubMed]
6. Bearson, B. L., S. M. Bearson, J. J. Uthe, S. E. Dowd, J. O. Houghton, I. Lee, M. J. Toscano, and D. C. Lay, Jr.2008. Iron regulated genes of Salmonella enterica serovar Typhimurium in response to norepinephrine and the requirement of fepDGC for norepinephrine-enhanced growth. Microbes Infect. 10:807-816. [PubMed]
7. Breustedt, D. A., I. P. Korndörfer, B. Redl, and A. Skerra.2005. The 1.8-Å crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands. J. Biol. Chem. 280:484-493. [PubMed]
8. Breustedt, D. A., D. L. Schönfeld, and A. Skerra.2006. Comparative ligand-binding analysis of ten human lipocalins. Biochim. Biophys. Acta 1764:161-173. [PubMed]
9. Burton, C. L., S. R. Chhabra, S. Swift, T. J. Baldwin, H. Withers, S. J. Hill, and P. Williams.2002. The growth response of Escherichia coli to neurotransmitters and related catecholamine drugs requires a functional enterobactin biosynthesis and uptake system. Infect. Immun. 70:5913-5923. [PMC free article] [PubMed]
10. Coulanges, V., P. Andre, and D. J. Vidon.1998. Effect of siderophores, catecholamines, and catechol compounds on Listeria spp. Growth in iron-complexed medium. Biochem. Biophys. Res. Commun. 249:526-530. [PubMed]
11. Crosa, J. H., and C. T. Walsh.2002. Genetics and assembly line enzymology of siderophore biosynthesis in bacteria. Microbiol. Mol. Biol. Rev. 66:223-249. [PMC free article] [PubMed]
12. Davis, G. C., P. T. Kissinger, and R. E. Shoup.1981. Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography. Anal. Chem. 53:156-159. [PubMed]
13. Dertz, E. A., J. Xu, A. Stintzi, and K. N. Raymond.2006. Bacillibactin-mediated iron transport in Bacillus subtilis. J. Am. Chem. Soc. 128:22-23. [PubMed]
14. Devireddy, L. R., C. Gazin, X. Zhu, and M. R. Green.2005. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123:1293-1305. [PubMed]
15. Devireddy, L. R., J. G. Teodoro, F. A. Richard, and M. R. Green.2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293:829-834. [PubMed]
16. Dowd, S. E.2007. Escherichia coli O157:H7 gene expression in the presence of catecholamine norepinephrine. FEMS Microbiol. Lett. 273:214-223. [PubMed]
17. Fischbach, M. A., H. Lin, D. R. Liu, and C. T. Walsh.2006. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat. Chem. Biol. 2:132-138. [PubMed]
18. Fischbach, M. A., H. Lin, D. R. Liu, and C. T. Walsh.2005. In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. Proc. Natl. Acad. Sci. USA 102:571-576. [PubMed]
19. Fischbach, M. A., H. Lin, L. Zhou, Y. Yu, R. J. Abergel, D. R. Liu, K. N. Raymond, B. L. Wanner, R. K. Strong, C. T. Walsh, A. Aderem, and K. D. Smith.2006. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl. Acad. Sci. USA 103:16502-16507. [PubMed]
20. Flo, T. H., K. D. Smith, S. Sato, D. J. Rodriguez, M. A. Holmes, R. K. Strong, S. Akira, and A. Aderem.2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921. [PubMed]
21. Fluckinger, M., H. Haas, P. Merschak, B. J. Glasgow, and B. Redl.2004. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob. Agents Chemother. 48:3367-3372. [PMC free article] [PubMed]
22. Freestone, P. P., R. D. Haigh, P. H. Williams, and M. Lyte.2003. Involvement of enterobactin in norepinephrine-mediated iron supply from transferrin to enterohaemorrhagic Escherichia coli. FEMS Microbiol. Lett. 222:39-43. [PubMed]
23. Freestone, P. P., M. Lyte, C. P. Neal, A. F. Maggs, R. D. Haigh, and P. H. Williams.2000. The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J. Bacteriol. 182:6091-6098. [PMC free article] [PubMed]
24. Freestone, P. P., P. H. Williams, R. D. Haigh, A. F. Maggs, C. P. Neal, and M. Lyte.2002. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 18:465-470. [PubMed]
25. Goetz, D. H., M. A. Holmes, N. Borregaard, M. E. Bluhm, K. N. Raymond, and R. K. Strong.2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10:1033-1043. [PubMed]
26. Hantke, K., G. Nicholson, W. Rabsch, and G. Winkelmann.2003. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc. Natl. Acad. Sci. USA 100:3677-3682. [PubMed]
27. Hoette, T. M., R. J. Abergel, J. Xu, R. K. Strong, and K. N. Raymond.2008. The role of electrostatics in siderophore recognition by the immunoprotein siderocalin. J. Am. Chem. Soc. 130:17584-17592. [PMC free article] [PubMed]
28. Holmes, M. A., W. Paulsene, X. Jide, C. Ratledge, and R. K. Strong.2005. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 13:29-41. [PubMed]
29. Hvidberg, V., C. Jacobsen, R. K. Strong, J. B. Cowland, S. K. Moestrup, and N. Borregaard.2005. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 579:773-777. [PubMed]
30. Iannetti, A., F. Pacifico, R. Acquaviva, A. Lavorgna, E. Crescenzi, C. Vascotto, G. Tell, A. M. Salzano, A. Scaloni, E. Vuttariello, G. Chiappetta, S. Formisano, and A. Leonardi.2008. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. USA 105:14058-14063. [PubMed]
31. Jewett, S. L., S. Eggling, and L. Geller.1997. Novel method to examine the formation of unstable 2:1 and 3:1 complexes of catecholamines and iron(III). J. Inorg. Biochem. 66:165-173.
32. Kerkut, G. A.1973. Catecholamines in invertebrates. Br. Med. Bull. 29:100-103. [PubMed]
33. Kulma, A., and J. Szopa.2007. Catecholamines are active compounds in plants. Plant Science 172:433-440.
34. Linert, W., E. Herlinger, R. F. Jameson, E. Kienzl, K. Jellinger, and M. B. Youdim.1996. Dopamine, 6-hydroxydopamine, iron, and dioxygen—their mutual interactions and possible implication in the development of Parkinson's disease. Biochim. Biophys. Acta 1316:160-168. [PubMed]
35. Loomis, L. D., and K. N. Raymond.1991. Solution equilibria of enterobactin and metal-enterobactin complexes. Inorg. Chem. 30:906-911.
36. Martin, R. B., J. Savory, S. Brown, R. L. Bertholf, and M. R. Wills.1987. Transferrin binding of Al3+ and Fe3+. Clin. Chem. 33:405-407. [PubMed]
37. May, J. J., T. M. Wendrich, and M. A. Marahiel.2001. The dhb operon of Bacillus subtilis encodes the biosynthetic template for the catecholic siderophore 2,3-dihydroxybenzoate-glycine-threonine trimeric ester bacillibactin. J. Biol. Chem. 276:7209-7217. [PubMed]
38. McPherson, A.1999. Crystallization of biological macromolecules. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Miethke, M., O. Klotz, U. Linne, J. J. May, C. L. Beckering, and M. A. Marahiel.2006. Ferri-bacillibactin uptake and hydrolysis in Bacillus subtilis. Mol. Microbiol. 61:1413-1427. [PubMed]
40. Miethke, M., and M. A. Marahiel.2007. Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71:413-451. [PMC free article] [PubMed]
41. Mori, K., H. T. Lee, D. Rapoport, I. R. Drexler, K. Foster, J. Yang, K. M. Schmidt-Ott, X. Chen, J. Y. Li, S. Weiss, J. Mishra, F. H. Cheema, G. Markowitz, T. Suganami, K. Sawai, M. Mukoyama, C. Kunis, V. D'Agati, P. Devarajan, and J. Barasch.2005. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Investig. 115:610-621. [PubMed]
42. Nakano, M., A. Takahashi, Y. Sakai, M. Kawano, N. Harada, K. Mawatari, and Y. Nakaya.2007. Catecholamine-induced stimulation of growth in Vibrio species. Lett. Appl. Microbiol. 44:649-653. [PubMed]
43. Newton, S. M., J. D. Igo, D. C. Scott, and P. E. Klebba.1999. Effect of loop deletions on the binding and transport of ferric enterobactin by FepA. Mol. Microbiol. 32:1153-1165. [PubMed]
44. Nurchi, V. M., T. Pivetta, J. I. Lachowicz, and G. Crisponi.2009. Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators. J. Inorg. Biochem. 103:227-236. [PubMed]
45. O'Donnell, P. M., H. Aviles, M. Lyte, and G. Sonnenfeld.2006. Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin. Appl. Environ. Microbiol. 72:5097-5099. [PMC free article] [PubMed]
46. Ollinger, J., K. B. Song, H. Antelmann, M. Hecker, and J. D. Helmann.2006. Role of the Fur regulon in iron transport in Bacillus subtilis. J. Bacteriol. 188:3664-3673. [PMC free article] [PubMed]
47. Raymond, K. N., and C. J. Carrano.1979. Coordination chemistry and microbial iron transport. J. Am. Chem. Soc. 12:183-190.
48. Russell, R. M.1992. Nutritional assessment, p. 1151-1155. In J. B. Wyngaarden, L. H. Smith, Jr., and J. C. Bennett (ed.), Cecil textbook of medicine, 19th ed. W. B. Saunders Co., Philadelphia, PA.
49. Sambrook, J., and D. W. Russel.2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
50. Schaible, U. E., and S. H. Kaufmann.2004. Iron and microbial infection. Nat. Rev. Microbiol. 2:946-953. [PubMed]
51. Schmidt-Ott, K. M., K. Mori, A. Kalandadze, J. Y. Li, N. Paragas, T. Nicholas, P. Devarajan, and J. Barasch.2006. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr. Opin. Nephrol. Hypertens. 15:442-449. [PubMed]
52. Sprencel, C., Z. Cao, Z. Qi, D. C. Scott, M. A. Montague, N. Ivanoff, J. Xu, K. M. Raymond, S. M. Newton, and P. E. Klebba.2000. Binding of ferric enterobactin by the Escherichia coli periplasmic protein FepB. J. Bacteriol. 182:5359-5364. [PMC free article] [PubMed]
53. Studier, F. W., and B. A. Moffatt.1986. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130. [PubMed]
54. Stülke, J., R. Hanschke, and M. Hecker.1993. Temporal activation of β-glucanase synthesis in Bacillus subtilis is mediated by the GTP pool. J. Gen. Microbiol. 139:2041-2045. [PubMed]
55. Troadec, J. D., M. Marien, F. Darios, A. Hartmann, M. Ruberg, F. Colpaert, and P. P. Michel.2001. Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. J. Neurochem. 79:200-210. [PubMed]
56. Vlisidou, I., M. Lyte, P. M. van Diemen, P. Hawes, P. Monaghan, T. S. Wallis, and M. P. Stevens.2004. The neuroendocrine stress hormone norepinephrine augments Escherichia coli O157:H7-induced enteritis and adherence in a bovine ligated ileal loop model of infection. Infect. Immun. 72:5446-5451. [PMC free article] [PubMed]
57. Vogt, M., and A. Skerra.2001. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J. Mol. Recognit. 14:79-86. [PubMed]
58. von Euler, U.1961. Occurence of catecholamines in acrania and invertebrates. Nature 190:170. [PubMed]
59. Vopel, S., H. Mühlbach, and A. Skerra.2005. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity. Biol. Chem. 386:1097-1104. [PubMed]
60. Williams, P. H., W. Rabsch, U. Methner, W. Voigt, H. Tschape, and R. Reissbrodt.2006. Catecholate receptor proteins in Salmonella enterica: role in virulence and implications for vaccine development. Vaccine 24:3840-3844. [PubMed]
61. Yang, J., K. Mori, J. Y. Li, and J. Barasch.2003. Iron, lipocalin, and kidney epithelia. Am. J. Physiol. Renal Physiol. 285:F9-F18. [PubMed]
62. Zawadzka, A. M., R. J. Abergel, R. Nichiporuk, U. N. Andersen, and K. N. Raymond.2009. Siderophore-mediated iron acquisition systems in Bacillus cereus: identification of receptors for anthrax virulence-associated petrobactin. Biochemistry 48:3645-3657. [PMC free article] [PubMed]
63. Zhu, M., M. Valdebenito, G. Winkelmann, and K. Hantke.2005. Functions of the siderophore esterases IroD and IroE in iron-salmochelin utilization. Microbiology 151:2363-2372. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)